Literature DB >> 6548228

Characterization of the extracellular bactericidal factors of rat alveolar lining material.

J D Coonrod, R L Lester, L C Hsu.   

Abstract

The surfactant fraction (55,000-g pellet) of leukocyte-free rat bronchoalveolar lavage fluid contains factors that rapidly kill and lyse pneumococci. These factors were purified and identified biochemically by using a quantitative bactericidal test to monitor fractionation procedures. 91% of the antipneumococcal activity of rat surfactant was recovered in chloroform after extraction of rat surfactant with chloroform-methanol (Bligh-Dyer procedure). After chromatography on silicic acid with chloroform, acetone, and methanol, all detectable antibacterial activity (approximately 80% of the initial activity) eluted with the neutral lipids in chloroform. When rechromatographed on silicic acid with hexane, hexane-chloroform, and chloroform, the antibacterial activity eluted with FFA. Thin-layer chromatography (TLC) established that the antibacterial activity was confined to the FFA fraction. Gas-liquid chromatography showed that the fatty acid fraction contained a mixture of long-chain FFA (C12 to C22) of which 66.7% were saturated and 32.4% were unsaturated. The quantity of TLC-purified FFA needed to kill 50% of 10(8) pneumococci under standardized conditions (one bactericidal unit) was 10.6 +/- 0.5 micrograms. Purified FFA acted as detergents, causing release of [3H]choline from pneumococcal cell walls and increased bacterial cell membrane permeability, evidenced by rapid unloading of 3-O-[3H]methyl-D-glucose. FFA acting as detergents appear to account for the bactericidal and bacteriolytic activity of rat pulmonary surfactant for pneumococci.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548228      PMCID: PMC425294          DOI: 10.1172/JCI111537

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  The lytic effect of lysolecithin on acholeplasmas and mycoplasmas.

Authors:  L V Soltesz; P A Mårdh
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-08

Review 2.  Host resistance factors in human milk.

Authors:  A S Goldman; C W Smith
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

3.  Physicochemical effects of long chain fatty acids on bacterial cells and their protoplasts.

Authors:  H Galbraith; T B Miller
Journal:  J Appl Bacteriol       Date:  1973-12

4.  Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material.

Authors:  F M LaForce; W J Kelly; G L Huber
Journal:  Am Rev Respir Dis       Date:  1973-10

5.  The function of human alveolar macrophages.

Authors:  M C Territo; D W Golde
Journal:  J Reticuloendothel Soc       Date:  1979-01

6.  Antimicrobial effect of simple lipids with different branches at the methyl end group.

Authors:  K Larsson; B Norén; G Odham
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

7.  The inhibitory action of fatty acids on the growth of Escherichia coli.

Authors:  J P Fay; R N Farias
Journal:  J Gen Microbiol       Date:  1975-12

8.  The role of autolysins in cell death.

Authors:  A Tomasz
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

9.  Effects of acetate and other short-chain fatty acids on sugar and amino acid uptake of Bacillus subtilis.

Authors:  C W Sheu; W N Konings; E Freese
Journal:  J Bacteriol       Date:  1972-08       Impact factor: 3.490

10.  Complement receptors of rat macrophages.

Authors:  J D Coonrod; S R Rehm
Journal:  J Reticuloendothel Soc       Date:  1982-02
View more
  17 in total

Review 1.  The role of surfactant in the pulmonary reaction to mineral particles.

Authors:  A G Heppleston
Journal:  Int J Exp Pathol       Date:  1991-10       Impact factor: 1.925

2.  Impaired antipneumococcal activity of bronchoalveolar lining material of neonatal rats.

Authors:  J D Coonrod; M C Jarrells
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.

Authors:  Zvjezdana Sever-Chroneos; Agnieszka Krupa; Jeremy Davis; Misbah Hasan; Ching-Hui Yang; Jacek Szeliga; Mathias Herrmann; Muzafar Hussain; Brian V Geisbrecht; Lester Kobzik; Zissis C Chroneos
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

4.  Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.

Authors:  P Rauprich; O Möller; G Walter; E Herting; B Robertson
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 5.  Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.

Authors:  Michael B Fessler; Ross S Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

6.  Candidacidal factors in murine bronchoalveolar lavage fluid.

Authors:  K M Nugent; R B Fick
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Ovine pulmonary surfactant induces killing of Pasteurella haemolytica, Escherichia coli, and Klebsiella pneumoniae by normal serum.

Authors:  K A Brogden
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

8.  Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b.

Authors:  G B Toews; D A Hart; E J Hansen
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

9.  Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.

Authors:  R F Parker; J K Davis; D K Blalock; R B Thorp; J W Simecka; G H Cassell
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

10.  Intrapulmonary growth of Staphylococcus aureus in rats during induced atelectasis.

Authors:  D Frederick; E L Pesanti
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.